Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e27e723c3f05c10ca760291231bacfb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16011 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
filingDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3861a3a16f6876f5023b7ff06728fade http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6739c688f36b93768e3a8c8eb797560 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9dc0bb8ded1d8b148fd18040793b55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7aca3c659e553b899afbdffc7dbf8a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf291f06925cd9ec8f8ae40fac06243 |
publicationDate |
2006-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006099177-A1 |
titleOfInvention |
Methods for treating HIV infected subjects |
abstract |
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the accessory molecule are described. T cell proliferation occurs in the absence of exogenous growth factors or accessory cells. T cell activation is accomplished by stimulating the T cell receptor (TCR)/CD3 complex or the CD2 surface protein. To induce proliferation of an activated population T cells, an accessory molecule on the surface of the T cells, such as CD28, is stimulated with a ligand which binds the accessory molecule. The T cell population expanded by the method of the invention can be genetically transduced and used for immunotherapy or can be used in methods of diagnosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512288-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3128015-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633463-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018039400-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479755-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008150814-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11268058-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560547-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11351236-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111727241-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382965-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530251-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732042-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344073-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021080847-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006205069-A1 |
priorityDate |
1988-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |